Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2024-06-28

Original market date: See footnote 1

2024-06-28

Product name:

MACROSYN

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02544229

Product Monograph/Veterinary Labelling:

Date: 2023-09-20 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

BIMEDA-MTC ANIMAL HEALTH INC
420 Beaverdale Rd.
Cambridge
Ontario
Canada N3C 2W4

Class:

Veterinary

Species:

Cattle ,  Swine (pigs) ,  Sheep

Dosage form(s):

Solution

Route(s) of administration:

Subcutaneous ,  Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

Anatomical Therapeutic Chemical (ATC): See footnote 4

Not Applicable

Active ingredient group (AIG) number:See footnote5

0151667001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
TULATHROMYCIN 100 MG / ML
Version 4.0.3

"Page details"

Date modified: